Wellington Partners

Wellington Ventures is a venture capital firm specializing in seed stage, start-ups, early stage, late stage, expansion stage, maturity, and growth capital investments. It primarily invests in the technology and life sciences sector. In the technology sector the firm invests in digital media, resource efficiency, and software. In the life sciences sector it invests in medical technology, digital health diagnostics, therapeutics, and industrial biotechnology. Within digital media, it invests in social, local, and/or mobile products and services, shifting media and entertainment consumption models, small businesses leveraging the web, next generation e-commerce model, financial services, financial technology, digital advertising, and gaming. Within the software sector, the firm prefers investment in cloud computing, SaaS, security, data centre software, and mobile business application. It invests in Artificial Intelligence, Food Tech and Ag Tech companies. Within medical technology, it invests in the application of innovative materials, nanotechnology, microelectronics and information technology in medical devices, drug device combinations, and minimally invasive procedures. Within diagnosis, the firm invests in personalize medicine, companion diagnostics, point-of –care diagnosis, monitoring of chronic diseases, early diagnosis of life-threatening diseases such as cancer. It also invests in cleantech, electronics, health science, and medical equipments. The firm seeks to invest in companies based across Europe, German speaking countries, Asia, and the United States. The firm seeks to invest between €7 million ($8.215 million) and €10 million ($11.73 million) in companies with sales value upto $2 million, Enterprise value between $1 million and $ 5 million, and EBITDA upto $0.5 million. It leads financing rounds ranging from €0.5 million ($0.66 million) to €20 million ($26.36 million), in the technology sector, and depending on the maturity of the company, the firm's own commitment can go as high as €15 million ($19.77 million). In case of the life sciences sector, the firm leads financing rounds ranging from €1 million ($1.173 million) to €10 million ($11.73 million) or more, in the technology sector, and depending on the maturity of the company, the firm's own commitment can go as high as €10 million ($11.73 million). Wellington Partners Venture Capital GmbH was founded in 1991 and is based in Munich, Germany with additional offices in Zurich, Switzerland; London, United Kingdom.

Eric Archambeau

General Partner

FB

Frank Böhnke

General Partner

Rolf Christof Dienst

Founder

Stuart Essig

Venture Partner

JF

Johannes Fischer

Principal

VG

Varun Gupta

Principal

Regina Hodits

Managing Partner

Harald Keller

Managing Partner, CFO

Ernst Mannheimer

General Partner

KN

Karl Naegler

Managing Partner

Karl Nägler

Managing Partner

Eberhard Plattfaut

Venture Partner, Europe

Erich Schlick

Venture Partner

Rainer Strohmenger

Managing Partner

AU

Arturo Urrios

Principal

229 past transactions

Quanta

Series C in 2019
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Tricares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Hailo

Venture Round in 2013
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

EyeEm

Seed Round in 2011
EyeEm Mobile GmbH operates as a photography community and platform company globally. It offers EyeEm, a place for photographers of various abilities to share, interact, and learn about taking pictures on various devices, as well as attracts brands and media that want to feature photos in magazines, digital media, and advertising. The company’s API gives developers access to various albums and photos. EyeEm Mobile GmbH was founded in 2011 and is based in Berlin, Germany with talent in San Francisco and New York.

Cavendish Kinetics

Series B in 2006
Cavendish Kinetics, Inc. designs, manufactures, and markets tunable components for RF circuits for cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. It offers antenna tuners for various RF applications. The company offers its products directly to customers worldwide. Cavendish Kinetics, Inc. was founded in 1994 and is headquartered in San Jose, California with an additional office in s-Hertogenbosch, the Netherlands. As of October 4, 2019, Cavendish Kinetics, Inc. operates as a subsidiary of Qorvo, Inc.

Jellynote

Seed Round in 2016
Jellynote is the go-to-destination for over 1 million aspiring musicians; a loyal community who enjoy sheets, tabs and chords, original video content and the opportunity to connect with one-another in the Jellynote universe. Jellynote has developed all of its proprietary technology in-house, delivering an intuitive AI-powered edtech platform to its fans. Jellynote sells premium subscriptions and generates revenue from ads. Jellynote offers over 400,000 songs that you can be played to learn through original artist video master classes, video tutorials, sheets, tabs, chords and instrument view for a wide range of instruments. The game mode provides instant feedback and social mode connects musicians share their tastes in music. The Jellynote universe demonstrates how music can connect people in a world that is getting more and more divided. Available on Smartphone and desktop.

Dalia Research

Seed Round in 2015
Dalia develops B2B/SaaS solutions to facilitate market and opinion research in >100 countries. They harness the app economy and advanced data science to distribute millions of micro-surveys worldwide to gather and analyse real-time data on consumer attitudes, public opinion, and market trends. Backed by some of Europe’s leading venture capital firms, Dalia is a dynamic and fast-paced tech startup with an exceptionally talented team from 19 different countries driven by one mission: to generate information that helps us better understand the world around us.

Astaro

Series A in 2003
[Astaro](http://www.astaro.com/) develops a complete line of network security products including the Astaro Security Gateway software and Astaro Security Gateway line of security appliances. All Astaro products offer nine security applications in three categories - Web Security, Email Security and Network Security - fully integrated on a single management platform. Astaro products are distributed by a worldwide network of 350 solutions partners who offer local support and services. via: [Astaro](http://www.astaro.com/)

Ztory

Seed Round in 2014
Ztory is a Swedish startup that gives readers access to an ever growing stockpile of magazines, children’s books and other illustrated publications for a fixed price each month. Our mission is to develop peoples interests by connecting them to the best publications on subjects they love.

Cavendish Kinetics

Venture Round in 2011
Cavendish Kinetics, Inc. designs, manufactures, and markets tunable components for RF circuits for cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. It offers antenna tuners for various RF applications. The company offers its products directly to customers worldwide. Cavendish Kinetics, Inc. was founded in 1994 and is headquartered in San Jose, California with an additional office in s-Hertogenbosch, the Netherlands. As of October 4, 2019, Cavendish Kinetics, Inc. operates as a subsidiary of Qorvo, Inc.

Proximic, Inc.

Series C in 2010
Digital advertising environments - display, mobile, video - are increasingly complex and require fundamentally new approaches to handling that complexity. Our approach to solving for this complexity is to bring a level of control to our customers to help them best manage their programmatic advertising requirements. Efficient markets operate best when both buyer and seller have complete control and transparency over what is being bought and sold. Proximic’s mission is to create that environment, at scale, and without adding excessive costs to the ecosystem.

EnOcean GmbH

Series C in 2005
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

import.io

Seed Round in 2013
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Oxford Immunotec

Series C in 2007
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Zopa

Series C in 2007
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

invendo medical

Venture Round in 2014
invendo medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed.

Quanta

Series D in 2021
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Immatics US

Series D in 2013
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

Immatics US

Series D in 2014
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

UiPath

Series E in 2020
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

YPlan

Seed Round in 2012
YPlan uncovers the best events every day so you can get out and Live Your City. Get the lowdown on cool dates, hidden culture and where to hang with friends. Discover, book, go – it's that simple. Flash your YPlan ticket and you're in. Founded in London in February, 2012, YPlan works directly with 3500+ event partners worldwide, has over 1.5 million users, and 1000+ 5* reviews on App Store.

Experteer World

Series B in 2010
Experteer offers an online platform that enables its users to search, find, and apply for job opportunities in Germany and Europe. It also enables individuals to find insights and articles about headhunter industry. Experteer was founded by Christian Gottsch and Konstantin Urban and is based in Munich, Germany.

UiPath

Series D in 2019
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.
AMBOSS is a medical technology company with offices in New York, Berlin and Cologne. Its knowledge platform has fundamentally changed the way medical know-how is acquired and utilized at the point-of-care. Students use the interactive library and high-yield question bank for general study and exam preparation, while doctors rely on AMBOSS to make effective clinical decisions guided by evidence-based recommendations. Founded in 2012 by doctors for doctors, the company’s international team has grown to over 200 physicians, scientists and software engineers, all striving to better serve doctors around the world. Today, more than half a million healthcare professionals in over 180 countries rely on AMBOSS.

CoMentis

Series C in 2007
CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer's disease (AD), age-related macular degeneration (AMD) and other cognitive disorders. Originally founded in 2004 as Athenagen, Inc., the company was re-named CoMentis following its August 2006 merger with Zapaq, Inc., which created a leading neurovascular disease franchise.

Tonsser

Seed Round in 2016
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

Mapillary

Series A in 2016
Mapillary AB operates an online street-level imagery platform that scales and automates mapping through collaboration, cameras, and computer vision. The company enables users to collect photos that are combined into a collective street level photo view through tools, such as smartphones and action cameras. It offers updated maps, automated mapping, mapillary driver, desktop uploader, and command line tools. The company was founded in 2013 and is based in Malmö, Sweden. As of June 18, 2020, Mapillary AB operates as a subsidiary of Facebook, Inc.

Artfinder

Series B in 2012
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage

eWise Group Inc.

Venture Round in 2011
eWise is a leading international provider of Personal Financial Management and Account Aggregation solutions. eWise Money Manager is used by many of the worlds most innovative banks including HSBC, Westpac and First Direct. Founded in 2000 and headquartered in Switzerland, eWise has operations in Europe, Asia, America and Australia.

glo AB

Series C in 2010
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

Quanta

Series A in 2009
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

AMBOSS GmbH // MIAMED GmbH

Seed Round in 2015
AMBOSS is a medical technology company with offices in New York, Berlin and Cologne. Its knowledge platform has fundamentally changed the way medical know-how is acquired and utilized at the point-of-care. Students use the interactive library and high-yield question bank for general study and exam preparation, while doctors rely on AMBOSS to make effective clinical decisions guided by evidence-based recommendations. Founded in 2012 by doctors for doctors, the company’s international team has grown to over 200 physicians, scientists and software engineers, all striving to better serve doctors around the world. Today, more than half a million healthcare professionals in over 180 countries rely on AMBOSS.

Blackbuck

Series D in 2019
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

Adrenomed AG

Series E in 2020
Adrenomed AG, a biopharmaceutical company, engages in the development of monoclonal antibody therapies for the treatment of sepsis. The company develops Adrecizumab, a humanized monoclonal antibody drug candidate against Adrenomedullin, a vasoactive peptide hormone released by vascular endothelial cells. Adrenomed AG was founded in 2009 and is based in Hennigsdorf, Germany.

BridgeCo

Venture Round in 2009
BridgeCo offers processor IC and software platforms for connecting Internet media sources, computers and consumer electronics throughout the home. BridgeCo platforms are targeted at the market for stand-alone after-market and embedded audio applications. BridgeCo platforms are the core technologies underlying digital media players (DMPs), audio/video receivers (AVRs), musical instruments and external multi-channel sound cards.

Experteer World

Series C in 2011
Experteer offers an online platform that enables its users to search, find, and apply for job opportunities in Germany and Europe. It also enables individuals to find insights and articles about headhunter industry. Experteer was founded by Christian Gottsch and Konstantin Urban and is based in Munich, Germany.

Experteer World

Series A in 2007
Experteer offers an online platform that enables its users to search, find, and apply for job opportunities in Germany and Europe. It also enables individuals to find insights and articles about headhunter industry. Experteer was founded by Christian Gottsch and Konstantin Urban and is based in Munich, Germany.

GameDuell

Venture Round in 2008
GameDuell is a cross-platform games community, developing games for its website as well as for social networks and mobile devices. With more than 125 million registered players across all platforms, the Berlin-based company counts among the casual and social games providers in the Western markets. GameDuell offers a broad portfolio of over 70 casual online games, mostly developed in-house, such as Fluffy, Maya Pyramid, Bubble Speed, Jungle Jewels, and game classics like Hearts, Solitaire, and Pool. It has a team of 210 experienced members. GameDuell was founded in 2003 by Kai Bolik, Michael Kalkowski, and Boris Wasmuth GameDuell. It is based in San Francisco, C.A.
Garderos makes industrial-grade routers which are self-managing and cyber-secure. They work with their customers to make sure that their multi-site router projects are fully-functional and secure against cyber-attacks.

Immatics US

Series C in 2010
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

GOOM

Series A in 2009
Goom de part son expertise dans le domaine de la radio propose depuis 2007 d’allier la puissance de l’audio à l’interactivité du digital afin d’offrir à votre public des contenus impliquants.Les marques deviennent des medias c’est pourquoi nous développons aujourd’hui pour nos clients tous types de contenus audios ainsi que tous les supports de diffusion nécessaires à leur rayonnement.Radio Interne, podcast audio , Radio de marque, radio évènementielle, émission, chronique… que cela soit pour le grand public , les collectivités ou pour une diffusion interne,notre ambition est de proposer une nouvelle expérience à votre public .

SumAll

Series A in 2012
SumAll Inc. develops and operates a data analytics platform that allows businesses to take control of their own data. The company offers sumall.com, a platform that provides a business information management service that tracks and consolidates information from social media, email, and traffic data about user’s business activity. It also provides various social media tools that allow clients to connect social media accounts for their users, and choose practical courses of action that allow users to grow their business. SumAll Inc. was founded in 2011 and is based in New York, New York.

Hailo

Series B in 2012
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

SidekickHealth

Series B in 2022
SidekickHealth is a digital therapeutics company that helps people prevent and manage chronic diseases. Our approach combines behavioral economics, gamification and artificial intelligence for a uniquely engaging experience that removes barriers to behavior change and expands the possibilities of health and well-being. Together with pharmaceutical companies and other organizations, we design personalized lifestyle change programs that improve health outcomes and treatment adherence, connect clinical experts and patient communities, and deliver data insights into some of the world's most pressing health challenges.

glo AB

Venture Round in 2017
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

Heliatek GmbH

Series D in 2016
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

Heliatek GmbH

Series B in 2009
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

EyeEm

Series A in 2013
EyeEm Mobile GmbH operates as a photography community and platform company globally. It offers EyeEm, a place for photographers of various abilities to share, interact, and learn about taking pictures on various devices, as well as attracts brands and media that want to feature photos in magazines, digital media, and advertising. The company’s API gives developers access to various albums and photos. EyeEm Mobile GmbH was founded in 2011 and is based in Berlin, Germany with talent in San Francisco and New York.

Oxford Immunotec

Series D in 2010
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Themis Bioscience GmbH

Series C in 2018
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

ComQi Holdings Limited

Venture Round in 2012
EnQii Holdings, Ltd. provides digital out-of-home solutions and services to media markets in the United Kingdom. It operates through Digital View Media, Redeemit, and Screen Edge companies. The Digital View Media provides various services, including consultancy; network design, channel, and content strategy advice; content creation, scheduling, and management; screen media network management and media management software; supply of media players; project management and installation services; network commissioning; and post installation network monitoring and maintenance. The Redeemit Limited, a marketing agency, offers sales promotion, event management, and loyalty programmes through mobile phones and SMS for brands, retailers, event promoters, venue owners, and agencies. The ScreenEdge is a content organization that provides channel strategy development and content creation services for digital out-of-home networks. The company is based in London, the United Kingdom. It has locations in New York, Hong Kong, Toronto, Melbourne, and Dubai.

NexWave Solutions

Series C in 2007
NexWave Solutions, S.A. develops embedded and device software for the consumer electronics market. It offers NexGUI, a graphical user interface framework for set top boxes, personal video recorders, DTVs, cameras, and camcorders; NEXGUIBUILDER to design and generate applications that use NexGUI; and NEXBROWSER, a small-footprint HTML/XHTML/CSS/JavaScript browser. The company also provides Blu-ray stack that forms the core of the Blu-ray products; LibTRON to enable quick migration of µITRON applications and middleware to a Linux-based environment; and NSI (NexWave Software Infrastructure), a component-based software infrastructure for embedded software development. It has representations in Seoul, Korea; and Beijing, Shanghai, and Shenzhen in China. NexWave Solutions, S.A. was founded in 1998 and is headquartered in Montpellier, France with additional offices in Silicon Valley (Bay Area), California; and Tokyo, Japan.

Rigontec GmbH

Series A in 2014
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

Hailo

Series A in 2012
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

Proximic, Inc.

Series A in 2007
Digital advertising environments - display, mobile, video - are increasingly complex and require fundamentally new approaches to handling that complexity. Our approach to solving for this complexity is to bring a level of control to our customers to help them best manage their programmatic advertising requirements. Efficient markets operate best when both buyer and seller have complete control and transparency over what is being bought and sold. Proximic’s mission is to create that environment, at scale, and without adding excessive costs to the ecosystem.

Adrenomed AG

Series D in 2018
Adrenomed AG, a biopharmaceutical company, engages in the development of monoclonal antibody therapies for the treatment of sepsis. The company develops Adrecizumab, a humanized monoclonal antibody drug candidate against Adrenomedullin, a vasoactive peptide hormone released by vascular endothelial cells. Adrenomed AG was founded in 2009 and is based in Hennigsdorf, Germany.

XING

Series A in 2005
XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom are based in german-speaking countries – use xing to boost their business, job, and career. Xing is a platform where professionals from all kinds of different industries can meet up, find jobs, colleagues, new assignments, cooperation partners, experts and generate business ideas. Members can meet and exchange views in over 50,000 specialist groups, while also getting together at networking events. The platform is operated by xing ag, which was founded in hamburg, germany, in 2003, has been publicly listed since 2006, and listed on the tecdax since september 2011. In december 2010, xing acquired amiando ag, a munich-based company and europe’s leading provider of online event management and ticketing. The acquisition of kununu gmbh, the leading platform for employer reviews in german-speaking countries, allows xing to extend its position as the social recruiting market leader.

IOmx Therapeutics AG

Series A in 2016
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.

Onfido Limited

Series B in 2016
Onfido digitally proves a user’s real identity using AI technology, by verifying their photo ID and comparing it to their facial biometrics. It means users and businesses can verify their online identities anywhere and anytime, without compromising on experience, inclusion, privacy or security. Onfido powers over 1,500 fintech, banking, and marketplace clients globally—helping them onboard more users while reducing risk. Identity underpins all transactions, and over the coming years, access to everything will be based on every user's ability to easily and securely prove their legal identity. This will change how we think of access—everything from opening a bank account to self-checking-in to a hotel, and ultimately voting.

glo AB

Series D in 2014
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

amiando

Seed Round in 2007
amiando is a pioneer in online event registration and ticketing. Since its foundation in 2006, amiando has become a leading software-as-a-service platform for professional events. amiando’s products help event organizers to reach a professional level of event organization which, until now, was only reserved for large corporations and event agencies. All tools are online-based and immediately available for use, without the need for software installation. Over 180,000 event organizers worldwide use amiando, including prestigious names such as Facebook, BMW, UNESCO, and Telefónica O2. amiando has been awarded numerous prizes for its innovative products, among them the “Technology Pioneer of 2010” at the World Economic Forum, and the “eco Internet Award” as the best business client portal. amiando has been part of XING AG since December 2010, an operator of the business network XING.

Definiens

Venture Round in 2014
Definiens is the provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives. Definiens is headquartered in Munich, Germany, and has offices throughout the United States.

BridgeCo

Venture Round in 2007
BridgeCo offers processor IC and software platforms for connecting Internet media sources, computers and consumer electronics throughout the home. BridgeCo platforms are targeted at the market for stand-alone after-market and embedded audio applications. BridgeCo platforms are the core technologies underlying digital media players (DMPs), audio/video receivers (AVRs), musical instruments and external multi-channel sound cards.

SAFE ID Solutions

Series A in 2005
SAFE ID Solutions AG provides integrated security solutions to the ID market for security and convenience in the issuance and personalization process. It offers secure eID systems and infrastructures with professional solutions for various markets, such as security, passport, ID card, visa, and border security infrastructures. The company provides document issuance solutions, including biometric enrolment, personalization management software, and optical and electronic personalization of ID documents, as well as offers document verification and border control solutions. Its customers include the governments of Kazakhstan, Spain, Turkey, Liechtenstein, Egypt, the Dominican Republic, and Costa Rica. The company has a strategic partnership with Singapore Technologies Electronics Ltd. SAFE ID Solutions AG was founded in 2003 and is headquartered in Munich, Germany. It operates showrooms in Munich, Germany; and Singapore, Singapore.

Rigontec GmbH

Series A in 2016
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

Rakuten France

Venture Round in 2005
Rakuten France operates a French online e-commerce website. It provides new, used, and collectable products at fixed prices for individuals and professionals in Europe. The company enables its customers to list items by entering the title or barcode of the item as well as the price at which the seller wishes to sell the product. It lists items under various categories, including books, music, DVD, VHS, video games, phones and PDAs, computing, electronics, sports, leisure, fashion, and toys and games. Rakuten France is formerly PriceMinister, a company acquired by Rakuten 2010. It was founded in August 2000 and is based in Paris, France.

import.io

Series A in 2016
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Immatics US

Series A in 2004
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

Zopa

Series D in 2012
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

IconOVir Bio

Series A in 2021
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.

MTM Laboratories

Series B in 2003
mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

UiPath

Series E in 2020
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

YPlan

Series B in 2014
YPlan uncovers the best events every day so you can get out and Live Your City. Get the lowdown on cool dates, hidden culture and where to hang with friends. Discover, book, go – it's that simple. Flash your YPlan ticket and you're in. Founded in London in February, 2012, YPlan works directly with 3500+ event partners worldwide, has over 1.5 million users, and 1000+ 5* reviews on App Store.

Negevtech

Series D in 2006
Negevtech, Ltd. provides patterned wafer optical inspection systems for the semiconductor industry. It offers Negevtech 3100, a wafer inspection system that offers wafer inspection of memory devices in front-end and back-end of line inspection applications. The company offers products for finding defects and controlling yields in semiconductor wafer processing. It has facilities in Texas, Idaho, Japan, Korea, Taiwan, China, Singapore, and Germany. The company was founded in 1999 and is based in Santa Clara, California with an additional office in Rehovot, Israel.

Implanet

Series D in 2010
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

UroMems

Series B in 2021
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

Hailo

Seed Round in 2011
FREE NOW (formerly mytaxi) is a leading mobility provider. FREE NOW currently operates in London, Brighton, Edinburgh, Manchester, Nottingham, Oxford, Reading, Derby and Leicester. With two requests every second, FREE NOW directly connects passengers and drivers with just two taps of the app. FREE NOW is part of the mobility joint venture between BMW and Daimler, formed in February 2019. In July 2016, mytaxi announced the merger with Hailo, the leading taxi app in the UK and Ireland - an important step towards becoming Europe's largest e-hailing app.

UroMems

Series B in 2020
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

VoiceObjects

Venture Round in 2005
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis in several leading European dermatology centres.

Immatics US

Series E in 2017
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

Rigontec GmbH

Series A in 2015
Rigontec GmbH is a biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The company develops ImOl100, a compound stimulating the immune receptor retinoic acid-inducible gene I, which recognizes viral RNA. Its ImOl100 is also a minimal mimic of naturally occurring 3pRNA, a motif typically occurring in viral RNAs. The company’s compounds avoid the pitfalls of cancer vaccines, checkpoint inhibitors, and therapeutics based on the identification of tumor antigens. Rigontec GmbH was founded in 2014 and is based in Planegg, Germany. As of October 26, 2017, Rigontec GmbH operates as a subsidiary of Merck & Co., Inc.

Cayaba Care

Series A in 2022
Cayaba Care is a maternal health company offering community-based clinical services via technology-enabled multidisciplinary care teams.

Innovative Silicon

Series C in 2007
Innovative Silicon was founded to develop and commercialise Floating Body effect memory for SoC/MPU products used in diverse applications including handheld computers, games consoles, cellular communications devices, cameras. The company closed its first round of VC funding in 2003, completed its first 90nm megabit Z-RAM memory design in 2004 and its first 65nm designs in 2005. The company was founded in 2002 and is headquartered in Santa Clara, California with additional offices in Lausanne, Switzerland; and Yokohama, Japan.

SNIPR Biome ApS

Series A in 2019
SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases. The company uses CRISPR technology that can subvert elements of the endogenous bacterial CRISPR machinery to eliminate hazardous bacteria in vivo, providing the health professionals with medicines that selectively target and kill bacteria with specific DNA sequences.

VoiceObjects

Series B in 2004
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

EnOcean GmbH

Series B in 2004
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

YPlan

Series A in 2013
YPlan uncovers the best events every day so you can get out and Live Your City. Get the lowdown on cool dates, hidden culture and where to hang with friends. Discover, book, go – it's that simple. Flash your YPlan ticket and you're in. Founded in London in February, 2012, YPlan works directly with 3500+ event partners worldwide, has over 1.5 million users, and 1000+ 5* reviews on App Store.

Aloqa

Series A in 2009
Aloqa is a mobile service that proactively notifies users about interesting places, services, events, and people close to where they are. Once you download and start Aloqa, you need to just look at your phone and it shows you live information about interesting things in your vicinity like your favorite coffee shops, highly rated restaurants, local bargains and coupons, Facebook friends in the vicinity, even kid friendly events. When you change locations, Aloqa refreshes itself automatically and notifies you of the relevant set of services, points of interest, events, and friends close to your new location. Wherever you are, whenever you go. In addition, Aloqa provides an API for easy development of location-based services, especially for proactive and community oriented applications. Examples contain detecting automatically the proximity of two mobile targets (such as Facebook friends), sorting a buddy list by current distance and automatically updating the list as well as clique observation (show me when 3 out of 5 of my myspace girlfriends are nearby).

import.io

Series B in 2018
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Heliatek GmbH

Series D in 2017
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

Immatics US

Post in 2020
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

SuperSonic Imagine SA

Private Equity Round in 2013
SuperSonic Imagine SA operates as a medical technology company. It designs, develops, and markets Aixplorer, an ultrasound system. It has developed a technology that offers practitioners and patients a breakthrough in the diagnosis and follow up of breast, prostate, and thyroid cancers, as well as liver diseases. The company’s products include Aixplorer, an ultrasound system that renders images with exceptional definition, contrast, and resolution. It operates primarily in China, the United States, and France. The company was founded in 2005 and is headquartered in Aix-en-Provence, France. SuperSonic Imagine SA is a subsidiary of Hologic Hub Ltd.

UroMems

Series A in 2016
UroMems SAS designs, develops, and commercializes implantable medical devices. It manufactures MyoElectroMechanical System, an implantable, electronic artificial urinary sphincter (eAUS) for patients who suffer from severe urinary incontinence which increases the urethral pressure when the patient is engaged in a physically demanding activity and decreases the pressure when the patient's activities do not require high compression on the tissues. The company was founded in 2011 and is based in Grenoble, France.

Livebookings Holdings Ltd.

Venture Round in 2009
With a network of more than 65,000 restaurants worldwide and more than 27 million monthly visits, TheFork, a TripAdvisor® company, is the largest online restaurant reservation platform in Europe, Australia, and Latin America. The network operates in France and Switzerland as "LaFourchette" and in Spain as "ElTenedor" and in Italy, the Netherlands, Belgium, Portugal, Brazil, Denmark, Australia, Argentina, Brasil, Chile, Colombia, Mexico, Peru, and Uruguay as "TheFork."

AZZURRO Semiconductors

Venture Round in 2010
AZZURRO Semiconductors AG manufactures and markets gallium nitride on silicon (GaN-on-Si) epitaxial wafers. The company's products enable Light Emitting Diode (LED) and semiconductor development. AZZURRO Semiconductors AG was founded in 2003 and is headquartered in Magdeburg, Germany. As of April 30, 2014 AZZURRO Semiconductors AG is under liquidation.

Automattic Inc.

Funding Round in 2021
Automattic is the company behind WordPress.com and WordPress.com VIP, the cloud version of WordPress. Automattic hosts and supports all WordPress.com sites ensuring that there is continuous and strategic development of the software available to its users. Automattic also supports WordPress.com VIP, a premium service designed for large-scale enterprises. WordPress.com VIP combines the benefits of WordPress.com and the ability to run custom code. In addition, WordPress.com VIP offers companies a robust CMS and 24/7 service.

Swoopo

Series A in 2006
Online auction site with an alternative bidding system. As of April 2009, Swoopo auctioned over 10,000 products per month and had more than 1,200,000 registered customers. How it works: online customers buy “bids” in advance. They cost $0.75 each and are sold in packs of 30, 50, 100, 300 or 700. Bidders have the choice of placing single bids, or, using an electronic bid assistant called the “BidButler”. Alternatively, customers can bid via the phone. Every bid placed, increases the price of the product by 15c and the auction countdown by up to 20 seconds. To help keep track of the money spent on bidding, each auction displays the amount spent on bids by the customer and how much the bidder would save overall, if they won the auction at that moment. The ‘last bidder standing’ when the countdown reaches zero, wins the auction – usually at a very low price; winners save, on average, 65% when compared to the recommended retail price.

amiando

Series A in 2008
amiando is a pioneer in online event registration and ticketing. Since its foundation in 2006, amiando has become a leading software-as-a-service platform for professional events. amiando’s products help event organizers to reach a professional level of event organization which, until now, was only reserved for large corporations and event agencies. All tools are online-based and immediately available for use, without the need for software installation. Over 180,000 event organizers worldwide use amiando, including prestigious names such as Facebook, BMW, UNESCO, and Telefónica O2. amiando has been awarded numerous prizes for its innovative products, among them the “Technology Pioneer of 2010” at the World Economic Forum, and the “eco Internet Award” as the best business client portal. amiando has been part of XING AG since December 2010, an operator of the business network XING.

NEUWAY Pharma

Series A in 2015
NEUWAY Pharma GmbH had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.

Dalia Research

Seed Round in 2015
Dalia develops B2B/SaaS solutions to facilitate market and opinion research in >100 countries. They harness the app economy and advanced data science to distribute millions of micro-surveys worldwide to gather and analyse real-time data on consumer attitudes, public opinion, and market trends. Backed by some of Europe’s leading venture capital firms, Dalia is a dynamic and fast-paced tech startup with an exceptionally talented team from 19 different countries driven by one mission: to generate information that helps us better understand the world around us.

Livebookings Holdings Ltd.

Venture Round in 2011
With a network of more than 65,000 restaurants worldwide and more than 27 million monthly visits, TheFork, a TripAdvisor® company, is the largest online restaurant reservation platform in Europe, Australia, and Latin America. The network operates in France and Switzerland as "LaFourchette" and in Spain as "ElTenedor" and in Italy, the Netherlands, Belgium, Portugal, Brazil, Denmark, Australia, Argentina, Brasil, Chile, Colombia, Mexico, Peru, and Uruguay as "TheFork."

ImCheck Therapeutics SAS

Series C in 2022
ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

IOmx Therapeutics AG

Series B in 2021
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics addressing novel immune checkpoint modulators on tumor cells. By systematically screening human tumor cells, the Company has already identified a number of novel targets and analyzed their mode of action. The Company was founded on the successful concept of cancer immune-checkpoint therapy, which works by breaking down the inherent resistance mechanisms of tumors against immune attack. Immune resistance of tumors is often mediated by cell surface molecules that stimulate immune-inhibitory receptors on T cells. Reactivating the host immune response by neutralizing these negative interactions is the idea behind cancer immune-checkpoint therapy.

HowDo

Seed Round in 2012
HowDo is sound & picture chapters to capture epic stories of everyday knowledge.

AYOXXA

Series B in 2014
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.

Ember Technologies

Debt Financing in 2010
Ember is a design-led temperature control brand whose mission is to revolutionize the way people eat, drink and live. Founded by inventor and serial entrepreneur Clay Alexander, Ember designs and develops patented technology and products that disrupt industries across healthcare, wellness, consumer products and more. From inventing the world’s first temperature control smart mug, to revolutionizing the cold chain for temperature sensitive medicines, Ember is creating a multidisciplinary temperature control platform that brings precision temperature control to your fingertips.

Heliatek GmbH

Series C in 2014
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

Truphone

Series B in 2008
Truphone provides mobile network services. It has built state-of-the-art SIM software, intuitive management platforms. Truphone also enables other mobile operators to rapidly roll out support for eSIM enabled devices. With Truphone, enterprises and individuals are benefiting from our international SIM cards and worldwide subscriptions, providing global mobility.

BridgeCo

Series D in 2006
BridgeCo offers processor IC and software platforms for connecting Internet media sources, computers and consumer electronics throughout the home. BridgeCo platforms are targeted at the market for stand-alone after-market and embedded audio applications. BridgeCo platforms are the core technologies underlying digital media players (DMPs), audio/video receivers (AVRs), musical instruments and external multi-channel sound cards.

123.TV

Venture Round in 2011
German television channel, 123TV organizes cross-media auctions (TV and internet) on consumer products, for a public of all generations. The auction is reversed in the sense that the price fixed in advance to steady decreases over time until the amounts passed.

Orcan Energy

Private Equity Round in 2022
Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

CARISMA Therapeutics Inc.

Series C in 2022
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.

Festicket

Series A in 2014
Festicket empowers music fans with a seamless service to discover and book tickets and travel packages for music festivals worldwide. The platform offers an end-to-end experience for music travelers, an efficient two-sided marketplace for 1,000+ music festivals across 40 different countries, and a network of 2,000 suppliers for accommodation and travel packages.

Wazap

Series B in 2007
Wazap! is a vertical search engine, video game database, and social networking site that aims to distribute gaming news, rankings, cheats, downloads and reviews. It uses a search algorithm, developed internally, to rank indexed pages according to their relevance. Further relevance to the Search engine results page (SERP) is obtained from user interactivity. Users can "Top" or "Flop" any of the results on the SERP and influence its relevance. Wazap!’s "bot" or "crawler" finds gaming related sites across the internet and tags pages according to the pre-defined categories. They also use a user submission tool. Wazap! combines internal proprietary information with their indexed gaming-related information from the web. The results obtained are then accessibly displayed according to the derived quality, publisher submissions, user popularity and preference. Wazap! Was launched by Andreas Ruehrig and is based in Los Angeles, California.

GTX medical

Venture Round in 2021
GTX Medical is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

eGenesis

Series C in 2021
Egenesis Inc., a biotechnology company, operates as a gene editing and genome engineering that develops human transplantable organs, tissues, and cells. It offers a gene editing platform for developing human compatible organs. The company also provides development, such as gene engineering, single cell cloning, somatic cell nuclear/embryo transfer, organ procurement, and transplantation. The company was incorporated in 2015 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Dalia Research

Series A in 2017
Dalia develops B2B/SaaS solutions to facilitate market and opinion research in >100 countries. They harness the app economy and advanced data science to distribute millions of micro-surveys worldwide to gather and analyse real-time data on consumer attitudes, public opinion, and market trends. Backed by some of Europe’s leading venture capital firms, Dalia is a dynamic and fast-paced tech startup with an exceptionally talented team from 19 different countries driven by one mission: to generate information that helps us better understand the world around us.

Heliatek GmbH

Series A in 2007
Heliatek GmbH develops and manufactures organic solar films and photovoltaics cells. Its product includes HeliaSol, an organic photovoltaics (OPV) solution that can be applied to surfaces. The companys’s product is used for building, automotive, and pilot projects applications. The company serves building and construction material companies, automotive manufacturers, and suppliers. Heliatek GmbH has strategic partnerships with AGC Glass Europe, and Reckli China. The company was founded in 2006 and is based in Dresden, Germany.

Cobion

Venture Round in 2002
Cobion is a text and imaging analysis company. It was founded by Rene Seeber.

Tonsser

Series A in 2018
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

EnOcean GmbH

Venture Round in 2009
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

Evolva Holding SA

Post in 2009
Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small molecule drugs and other compounds. In particular their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.

Codetoys Oy

Series B in 2001
Codetoys Oy is an innovative enabler and creator of interactive games and entertainment content for mobile, wireless platforms. Organized in Helsinki, Finland in January 2000, SpringToys is owned by Sonera Corporation, Housemarque Inc., Eqvitec Partners and by the management. Sonera is an international forerunner in mobile communications and mobile-based services and applications.

WLAN AG

Venture Round in 2002
WLAN AG is a wireless local area network distributor. It focuses on the professional client support with regard to evaluation, planning, implementation, operation, and support of WLAN and network access control solutions. It offers its users with network engineering, operations, troubleshooting, and WLAN engineering services. The company offers solutions for network access controlling, public transport systems, and public WLAN. WLAN AG is a Switzerland-based company that was founded in 2004. The company was acquired by Swisscom Eurospot on March 7, 2003.

Implanet

Series B in 2009
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

Proximic, Inc.

Series A in 2006
Digital advertising environments - display, mobile, video - are increasingly complex and require fundamentally new approaches to handling that complexity. Our approach to solving for this complexity is to bring a level of control to our customers to help them best manage their programmatic advertising requirements. Efficient markets operate best when both buyer and seller have complete control and transparency over what is being bought and sold. Proximic’s mission is to create that environment, at scale, and without adding excessive costs to the ecosystem.

eGenesis

Series B in 2019
Egenesis Inc., a biotechnology company, operates as a gene editing and genome engineering that develops human transplantable organs, tissues, and cells. It offers a gene editing platform for developing human compatible organs. The company also provides development, such as gene engineering, single cell cloning, somatic cell nuclear/embryo transfer, organ procurement, and transplantation. The company was incorporated in 2015 and is based in Cambridge, Massachusetts with an additional office in New York, New York.

Symetis SA

Series B in 2009
Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.

Truphone

Series A in 2007
Truphone provides mobile network services. It has built state-of-the-art SIM software, intuitive management platforms. Truphone also enables other mobile operators to rapidly roll out support for eSIM enabled devices. With Truphone, enterprises and individuals are benefiting from our international SIM cards and worldwide subscriptions, providing global mobility.

Themis Bioscience GmbH

Series B in 2016
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Readmill

Series A in 2012
Readmill, a Berlin, Germany-based social and shareable reading platform. Led by CEO Henrik Berggren, Readmill allows users to highlight parts of an ebook, share these highlights with friends and start discussions around them. The company also announced partnerships with six major independent stores including Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch.

Artfinder

Venture Round in 2016
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage

Q-Layer

Series B in 2007
Q-layer was one of the first companies in the industry to create and end-to-end cloud automation product. Q-layer created and invented the virtual datacenter concept where complex IT resources were managed in what we called Virtual Datacenters at that time. Q-layer converged storage, virtualization & networking in one stack.

Cavendish Kinetics

Venture Round in 2014
Cavendish Kinetics, Inc. designs, manufactures, and markets tunable components for RF circuits for cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. It offers antenna tuners for various RF applications. The company offers its products directly to customers worldwide. Cavendish Kinetics, Inc. was founded in 1994 and is headquartered in San Jose, California with an additional office in s-Hertogenbosch, the Netherlands. As of October 4, 2019, Cavendish Kinetics, Inc. operates as a subsidiary of Qorvo, Inc.

Ingent

Series A in 2007
Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

Jellynote

Seed Round in 2014
Jellynote is the go-to-destination for over 1 million aspiring musicians; a loyal community who enjoy sheets, tabs and chords, original video content and the opportunity to connect with one-another in the Jellynote universe. Jellynote has developed all of its proprietary technology in-house, delivering an intuitive AI-powered edtech platform to its fans. Jellynote sells premium subscriptions and generates revenue from ads. Jellynote offers over 400,000 songs that you can be played to learn through original artist video master classes, video tutorials, sheets, tabs, chords and instrument view for a wide range of instruments. The game mode provides instant feedback and social mode connects musicians share their tastes in music. The Jellynote universe demonstrates how music can connect people in a world that is getting more and more divided. Available on Smartphone and desktop.

Orcan Energy

Series B in 2013
Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

UiPath

Series D in 2019
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

Dacuda

Venture Round in 2014
Dacuda is a computer vision company that redefines the capabilities of cameras with real-time 2D and 3D algorithms. As the leading pioneer in software 3D camera technology, Dacuda's mission is to bring 3D capturing to every consumer by making 3D content creation as easy as taking a video. Dacuda's software 3D camera helps scale existing 3D use cases to consumers with app-based scanning and enables novel experiences for Augmented and Virtual Reality headsets. Dacuda is headquartered in Zurich, Switzerland, with locations in Palo Alto, California and Shanghai, China.. Awards include: Venture Leaders Asia 2014, Gartner Cool Vendor 2013, Entrepreneur of the Year 2012 by Ernst & Young, HEC Prix Strategis 2012, Swiss Economic Award 2011, HSG Entrepreneur of the Year 2011, Swiss Innovation Prize by IDEE SUISSE, Venture Leaders 2010, Venture Kick, ETH Spin-Off Label, CTI Start-up Label

eCircle

Private Equity Round in 2010
eCircle provides software and services for email marketing in Europe. It offers software for email and SMS broadcasting, and email address data for newsletter mailings and email/SMS/MMS campaigns, as well as consulting services and social media functionalities. The company was founded in 1999 and is based in Munich, Germany with additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy.

SENSIMED

Series A in 2007
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Livebookings Holdings Ltd.

Venture Round in 2012
With a network of more than 65,000 restaurants worldwide and more than 27 million monthly visits, TheFork, a TripAdvisor® company, is the largest online restaurant reservation platform in Europe, Australia, and Latin America. The network operates in France and Switzerland as "LaFourchette" and in Spain as "ElTenedor" and in Italy, the Netherlands, Belgium, Portugal, Brazil, Denmark, Australia, Argentina, Brasil, Chile, Colombia, Mexico, Peru, and Uruguay as "TheFork."

Immatics US

Series B in 2007
Immatics US Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient, where they recognize and kill tumor cells. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company has a strategic cancer immunotherapy collaboration with Roche to research, develop, and commercialize various new cancer peptide antigen-based immunotherapies for targeting primarily gastric, prostate, and non-small cell lung cancer. Immatics US Inc. was founded in 2015 and is headquartered in Houston, Texas. Immatics US Inc. operates as a subsidiary of immatics biotechnologies GmbH.

MTM Laboratories

Series C in 2010
mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

EnOcean GmbH

Series D in 2008
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

Open Mobile Corp.

Venture Round in 2000
A new US-registered company with its roots in Scandinavia.

Astaro

Series B in 2004
[Astaro](http://www.astaro.com/) develops a complete line of network security products including the Astaro Security Gateway software and Astaro Security Gateway line of security appliances. All Astaro products offer nine security applications in three categories - Web Security, Email Security and Network Security - fully integrated on a single management platform. Astaro products are distributed by a worldwide network of 350 solutions partners who offer local support and services. via: [Astaro](http://www.astaro.com/)

EyeEm

Series B in 2015
EyeEm Mobile GmbH operates as a photography community and platform company globally. It offers EyeEm, a place for photographers of various abilities to share, interact, and learn about taking pictures on various devices, as well as attracts brands and media that want to feature photos in magazines, digital media, and advertising. The company’s API gives developers access to various albums and photos. EyeEm Mobile GmbH was founded in 2011 and is based in Berlin, Germany with talent in San Francisco and New York.

EnOcean GmbH

Series A in 2002
EnOcean GmbH manufactures and markets energy harvesting technology systems, sensors, and radio frequency communication solutions for building and home automation, lighting, industrial, automated meter reading, and environmental applications. Its products include energy converters, energy harvesting wireless sensors, controllers, and software, starter kits, and development tools to help OEMs to implement energy harvesting wireless modules and products. It sells its products through distributors in Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, the Netherlands, Norway, the Russian Federation, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, the United States, the United Kingdom, and other Eastern European countries. The company was founded in 2001 and is based in Oberhaching, Germany.

Koa Health B.V.

Series A in 2021
Koa Health is digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies. It delivers mental health support that is accessible, personalized, and effective across a range of conditions. They create digital tools and resources for mental health that encompass prevention, prediction, and treatment.

Enecsys

Series A in 2009
Enecsys Limited, develops, manufacturers, and markets world-leading, highly reliable, grid-connected solar micro inverters and monitoring systems that offer an outstanding value proposition for solar PV systems. The micro inverter accepts DC power from each solar module and converts it into clean AC power for supply to the electricity grid. The advantages of Enecsys solar micro inverters include: maximized energy harvest, improved safety, increased lifetime and reliability, enhanced performance monitoring, and simplified PV array design and installation. The monitoring system tracks, in real-time, the performance of each PV module and transmits the information through a robust built-in wireless communication system that connects to the Internet via a gateway. Headquartered in Cambridge, UK, the company also has sales and support offices in Bad Homburg, Germany; Redwood Shores, California, USA; and Taipei, Taiwan. For more information, please visit www.enecsys.com..

glo AB

Series E in 2016
glo AB develops and commercializes direct-emitting red, green, and blue display panels for displays, illumination, and automotive sectors. The company offers microLEDs products through original equipment manufacturer and manufacturing partners. Its products have application in phone and watch displays, virtual and augmented reality, tiled huge walls displays, on-retina displays, and television. The company was founded in 2005 and is based in Lund, Sweden with an office in Sunnyvale, California.

bonusbox

Seed Round in 2012
bonusbox GmbH provides online loyalty programs. It offers a customer retention platform that helps merchants in building and maintaining beneficial relationships with their customers. Its platform increases customers' basket values and promotes repeat buying. The company was founded in 2011 and is based in Berlin, Germany.

Minervax ApS

Series B in 2020
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. Confo Therapeutics employs its proprietary CONFO® technology to lock inherent unstable functional conformations of GPCRs as a superior starting point for drug discovery. CONFO® body-stabilized active state conformations of these receptors disclose previously inaccessible structural features empowering the discovery of novel agonists for better therapeutic intervention.

Proximic, Inc.

Series B in 2008
Digital advertising environments - display, mobile, video - are increasingly complex and require fundamentally new approaches to handling that complexity. Our approach to solving for this complexity is to bring a level of control to our customers to help them best manage their programmatic advertising requirements. Efficient markets operate best when both buyer and seller have complete control and transparency over what is being bought and sold. Proximic’s mission is to create that environment, at scale, and without adding excessive costs to the ecosystem.

4SC

Post in 2015
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Artfinder

Series A in 2011
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage

Soundtrack Your Brand Sweden AB

Venture Round in 2014
Soundtrack Your Brand is a Spotify joint venture and the exclusive provider of Spotify Business and Spotify Enterprise. We connect brands and fans, and our vision is to grow the music market and thereby support artists, so that they can give the world more great music

Festicket

Series B in 2016
Festicket empowers music fans with a seamless service to discover and book tickets and travel packages for music festivals worldwide. The platform offers an end-to-end experience for music travelers, an efficient two-sided marketplace for 1,000+ music festivals across 40 different countries, and a network of 2,000 suppliers for accommodation and travel packages.

ImCheck Therapeutics SAS

Series B in 2019
ImCheck Therapeutics SAS develops immunotherapeutics for patients with severe unmet medical needs. The company primarily focuses on immuno-oncology. It develops immunotherapy antibodies, which include immunomodulators and butyrophilins to treat a range of autoimmune diseases. The company was founded in 2015 and is based in Marseille, France.

Collax

Series A in 2005
Collax GmbH develops and offers Linux-based server solutions for small to medium sized companies. It offers Collax Business Server, a Linux-based server solution, which enables to build and maintain network; Collax OX Server, which is used for internal and global interchange of information; Collax Security Gateway, a network security solution for unified threat management; and appliances. The company's solutions include network security, solutions platform, and integration framework. In addition, it offers solutions, such as data, database, e-mail, collaboration, fax, proxy, Web-server via router, virtual private network, firewall, virus and spam protection, and Web content filters. The company was founded in 2005 and is based in Ismaning, Germany with additional offices in Munich, Germany; and Boston.

SumAll

Venture Round in 2012
SumAll Inc. develops and operates a data analytics platform that allows businesses to take control of their own data. The company offers sumall.com, a platform that provides a business information management service that tracks and consolidates information from social media, email, and traffic data about user’s business activity. It also provides various social media tools that allow clients to connect social media accounts for their users, and choose practical courses of action that allow users to grow their business. SumAll Inc. was founded in 2011 and is based in New York, New York.

Themis Bioscience GmbH

Series D in 2019
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Workframe

Series A in 2016
Workframe is the only workflow optimization solution purpose-built for the commercial real estate (CRE) industry. Our intuitive, web-based software application helps large corporate tenants, landlords, brokers and service providers gain unprecedented visibility into their workflow, and presents them with actionable data that can be leveraged to drive efficiency and cost savings. 
Soundtrack Your Brand is a Spotify joint venture and the exclusive provider of Spotify Business and Spotify Enterprise. We connect brands and fans, and our vision is to grow the music market and thereby support artists, so that they can give the world more great music

Wool and the Gang

Seed Round in 2013
Wool and the Gang is a global fashion brand that believes in exceptional design that’s Made Unique. Never factory made, each Wool and the Gang item is handcrafted or knitted by the Gang – the team of artisans and makers around the world. Their designs can also be bought as easy-to-follow Knit Kits, which allows you to knit your own customized Wool and the Gang designs at home.

MTM Laboratories

Series C in 2006
mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

Eastbeam

Venture Round in 2006
Eastbeam operates Wazap!, the largest gaming information portal in Japan.

Evolva Holding SA

Series B in 2009
Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small molecule drugs and other compounds. In particular their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches.

Middle Peak Medical

Series A in 2013
Middle Peak Medical is a privately held medical device company focused on the development and commercialization of a novel technology to treat mitral valve disease. The company’s proprietary device has application in both percutaneous catheter-based intervention, and in minimally invasive or open-heart cardiac surgery.

Sphingotec GmbH

Venture Round in 2018
Sphingotec GmbH develops biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury, and circulatory shock. The company was founded in 2002 and is based in Brandenburg, Germany.

Adviqo

Series D in 2007
ADVQ, founded in 2000 and headquartered in Berlin/Germany, is a diversified media group with multiple online and offline properties directed towards female audiences. It is the world market leader in live counseling services in the areas of life advice, therapeutic counseling and coaching advice. With over 350 employees and offices in 5 countries (Germany, UK, France, Spain, Poland) the company is operating TV channels, online marketplaces and eCommerce sites as well as mobile applications. The company is an exclusive advice content partner for leading women magazines such as Bild, Bild der Frau, IN Star&Style but also large online portals such as GMX, T-Online and Freenet. With a top management team with backgrounds from BigPoint, HomeAway.com, BWin.com, Axel Springer, T-Online and backed by renowned investors like Wellington Partners, AGF and the European Founders Fund – the company has enjoyed high double digit $M revenues and high profitability.

Codeonline

Series A in 2001
Codeonline Ltd., a developer of interactive mobile entertainment, and Springtoys, a developer of wireless gaming technology, have agreed to merge to create what they claim will be the world’s largest wireless entertainment company. Under the terms of the agreement, the merger will be carried out through a share swap.

Middle Peak Medical

Series A in 2013
Middle Peak Medical is a privately held medical device company focused on the development and commercialization of a novel technology to treat mitral valve disease. The company’s proprietary device has application in both percutaneous catheter-based intervention, and in minimally invasive or open-heart cardiac surgery.

GTX medical

Series A in 2016
GTX Medical is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Genticel

Series D in 2013
Genticel is a French clinical stage biotechnology company founded by Benedikt Timmerman in 2001 and focused on the development of innovative immunotherapies designed to treat virus infections and virus-induced diseases. Genticel aims to become a leader in immunotherapy in multiple indications, starting with HPV and HPV induced diseases such as cervical cancer.

ImevaX

Series A in 2014
ImevaX GmbH develops specific vaccines against pathogens, which cause chronic infectious diseases. The company creates specific vaccines against immune evasion factors to control chronic and nosocomial infections. It offers vaccine against helicobacter pylori, which colonizes the stomach and is the cause of ulcer disease and gastric cancer in humans. The company was founded in 2014 and is based in Munich, Germany.

import.io

Seed Round in 2014
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Orecon

Series A in 2008
Wave energy is the future and Orecon is making that future today's reality. The oceans are a source of immense and limitless power. Orecon is here to harness that power and convert it into sustainable and affordable electricity. Orecon's MRC has been designed specifically to do this. It's a robust and reliable wave energy device that uses the best tried and tested components on the market. And it's clean because respecting the oceans is as important to us as releasing the power within them.

Hintsa

Seed Round in 2015
Hintsa Performance Oy provides healthcare and wellbeing coaching services to companies, elite athletes, and private individuals in Finland. It offers advice, consultation, and programs in the areas of general health, mental energy, biomechanics, recovery, nutrition, and physical activity. The company was founded in 2014 and is based in Espoo, Finland.

Adconion Media Group

Series C in 2008
Adconian Media Group is a technology company that provides customized solutions and innovative products delivered across multiple screens on a single platform.  The company’s digital distribution platform enables content owners, app developers and device manufacturers to monetize their global audiences across multiple devices and screens. This is done by building proprietary data profiles and models on their consumers and then selling these profiles to the highest bidder in a real-time marketplace. The Adconion DDP is collecting data on the 50+ billion events a month that take place across the platform. This data is ingested, mapped, and segmented, providing Adconion with a 360° audience profile across one platform. Adconion Media Group wholly owns Adconion Direct, providing performance solutions spanning display, email and social media; along with smartclip, the video and brand advertising platform specializing in multi-screen delivery. Adconion Media Group was founded by Fred Krueger and Tyler Moebius in.

Enecsys

Series B in 2011
Enecsys Limited, develops, manufacturers, and markets world-leading, highly reliable, grid-connected solar micro inverters and monitoring systems that offer an outstanding value proposition for solar PV systems. The micro inverter accepts DC power from each solar module and converts it into clean AC power for supply to the electricity grid. The advantages of Enecsys solar micro inverters include: maximized energy harvest, improved safety, increased lifetime and reliability, enhanced performance monitoring, and simplified PV array design and installation. The monitoring system tracks, in real-time, the performance of each PV module and transmits the information through a robust built-in wireless communication system that connects to the Internet via a gateway. Headquartered in Cambridge, UK, the company also has sales and support offices in Bad Homburg, Germany; Redwood Shores, California, USA; and Taipei, Taiwan. For more information, please visit www.enecsys.com..

CARISMA Therapeutics Inc.

Series B in 2021
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.

Polares Medical S.A.

Series A in 2018
Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

ComQi Holdings Limited

Series B in 2008
EnQii Holdings, Ltd. provides digital out-of-home solutions and services to media markets in the United Kingdom. It operates through Digital View Media, Redeemit, and Screen Edge companies. The Digital View Media provides various services, including consultancy; network design, channel, and content strategy advice; content creation, scheduling, and management; screen media network management and media management software; supply of media players; project management and installation services; network commissioning; and post installation network monitoring and maintenance. The Redeemit Limited, a marketing agency, offers sales promotion, event management, and loyalty programmes through mobile phones and SMS for brands, retailers, event promoters, venue owners, and agencies. The ScreenEdge is a content organization that provides channel strategy development and content creation services for digital out-of-home networks. The company is based in London, the United Kingdom. It has locations in New York, Hong Kong, Toronto, Melbourne, and Dubai.

Adconion Media Group

Series A in 2007
Adconian Media Group is a technology company that provides customized solutions and innovative products delivered across multiple screens on a single platform.  The company’s digital distribution platform enables content owners, app developers and device manufacturers to monetize their global audiences across multiple devices and screens. This is done by building proprietary data profiles and models on their consumers and then selling these profiles to the highest bidder in a real-time marketplace. The Adconion DDP is collecting data on the 50+ billion events a month that take place across the platform. This data is ingested, mapped, and segmented, providing Adconion with a 360° audience profile across one platform. Adconion Media Group wholly owns Adconion Direct, providing performance solutions spanning display, email and social media; along with smartclip, the video and brand advertising platform specializing in multi-screen delivery. Adconion Media Group was founded by Fred Krueger and Tyler Moebius in.

webme

Series A in 2008
Webme is a web-hosting site that is based in Germany.

eCircle

Venture Round in 2000
eCircle provides software and services for email marketing in Europe. It offers software for email and SMS broadcasting, and email address data for newsletter mailings and email/SMS/MMS campaigns, as well as consulting services and social media functionalities. The company was founded in 1999 and is based in Munich, Germany with additional offices in the United Kingdom, France, Spain, the Netherlands, and Italy.

EndoStim, Inc.

Series D in 2016
EndoStim, Inc., a medical device company, develops and commercializes neurostimulation solutions for the treatment of gastro-esophageal reflux disease (GERD). Its solutions cover treatment for GERD through electrical stimulation. The company distributes its products throughout Europe, Asia, and Latin America. EndoStim was founded in 2009 and is based in Dallas, Texas.

Oxford Immunotec

Venture Round in 2012
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

CARISMA Therapeutics Inc.

Series A in 2018
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.

import.io

Seed Round in 2013
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

Spotify

Series B in 2009
Spotify AB provides a digital music-streaming service that gives on-demand access of songs on devices, computers, mobiles, tablets, and home entertainment systems. Its services allow subscribers to search and discover music collections of friends, artists, and celebrities; build a personal collection playlist; and share music on Spotify, Facebook, Twitter, blog, and via email with friends. It also offers research and development services in Sweden. The company was founded in 2008 and is headquartered in Stockholm, Sweden. Spotify AB operates as a subsidiary of Spotify Technology S.A.

SumAll

Series A in 2013
SumAll Inc. develops and operates a data analytics platform that allows businesses to take control of their own data. The company offers sumall.com, a platform that provides a business information management service that tracks and consolidates information from social media, email, and traffic data about user’s business activity. It also provides various social media tools that allow clients to connect social media accounts for their users, and choose practical courses of action that allow users to grow their business. SumAll Inc. was founded in 2011 and is based in New York, New York.

Replisaurus

Series A in 2006
Replisaurus Technologies develops metallization solutions for the electronics industry. It offers ElectroChemical Pattern Replication (ECPR), a metallization technology process for semiconductor manufacturing markets; production solutions, including master electrodes, integrated ECPR tools, chemicals, and processing guidelines; and die-to-die, die-to-wafer bonding, and nano imprint lithography solutions. The company’s products have applications in IC metallization, pad redistribution, and power metal/power distribution; integrated passive devices substrates, including coils, capacitors, and resistors; flip chip substrates, interposers, chip carriers, and SIP substrates; micro bumps; and nano electronics and micro systems metallization, opto substrates, and chip coils. Replisaurus Technologies AB offers its solutions to the manufacturers of packaging, substrates, optical components, and semiconductor devices.

Onfido Limited

Series A in 2015
Onfido digitally proves a user’s real identity using AI technology, by verifying their photo ID and comparing it to their facial biometrics. It means users and businesses can verify their online identities anywhere and anytime, without compromising on experience, inclusion, privacy or security. Onfido powers over 1,500 fintech, banking, and marketplace clients globally—helping them onboard more users while reducing risk. Identity underpins all transactions, and over the coming years, access to everything will be based on every user's ability to easily and securely prove their legal identity. This will change how we think of access—everything from opening a bank account to self-checking-in to a hotel, and ultimately voting.

Stipe Therapeutics

Series A in 2019
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer. The company has developed first-in-class drugs targeting intracellular protein-protein interactions of the STING Pathway; a major driver of innate immunity, and regulator of tumorigenesis and autoimmune disorders. The company has identified and validated compounds that sensitizes the STING pathway and by this modulates the tumor microenvironment to support a potent anti-tumoral response.

Zopa

Series B in 2006
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

Koa Health B.V.

Series A in 2020
Koa Health is digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies. It delivers mental health support that is accessible, personalized, and effective across a range of conditions. They create digital tools and resources for mental health that encompass prevention, prediction, and treatment.

Tonsser

Seed Round in 2017
Social network and utility app for youth soccer players who use Tonsser every week to keep track of their stats, improve their player rating, be inspired on how to improve and engage with their community.

Opvizor GmbH

Series A in 2014
Opvizor GmbH develops a cloud-based expert system, Opvizor which detects VMware configuration and operating issues within uploaded protocol files, configuration, event, and performance data. It discovers system integrity issues and helps to harden client’s system security; and provides administrators with security report, issues report, health check, and snapshot report. The company was founded in 2012 and is based in Vienna, Austria.

CARISMA Therapeutics Inc.

Series B in 2021
CARISMA Therapeutics Inc., a biotechnology company, develops CAR macrophages, an approach to immunotherapy. CARISMA Therapeutics Inc. was formerly known as CARMA Therapeutics Inc. and changed its name to CARISMA Therapeutics Inc. in June 2018. The company was incorporated in 2016 and is headquartered in Philadelphia, Pennsylvania.

SidekickHealth

Series A in 2020
SidekickHealth is a digital therapeutics company that helps people prevent and manage chronic diseases. Our approach combines behavioral economics, gamification and artificial intelligence for a uniquely engaging experience that removes barriers to behavior change and expands the possibilities of health and well-being. Together with pharmaceutical companies and other organizations, we design personalized lifestyle change programs that improve health outcomes and treatment adherence, connect clinical experts and patient communities, and deliver data insights into some of the world's most pressing health challenges.

Quanta

Series B in 2014
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Mapillary

Seed Round in 2015
Mapillary AB operates an online street-level imagery platform that scales and automates mapping through collaboration, cameras, and computer vision. The company enables users to collect photos that are combined into a collective street level photo view through tools, such as smartphones and action cameras. It offers updated maps, automated mapping, mapillary driver, desktop uploader, and command line tools. The company was founded in 2013 and is based in Malmö, Sweden. As of June 18, 2020, Mapillary AB operates as a subsidiary of Facebook, Inc.

Seesmic

Series B in 2008
Seesmic is a powerful suite of social media management and collaboration tools that provide businesses and individuals with everything they need to build and manage their brands online. With applications on [every platform](http://seesmic.com/products), including mobile devices, and a marketplace of over 80 third-party plugins, Seesmic is the most comprehensive solution on the market. Seesmic is headquartered in San Francisco and was founded by French entrepreneur [Loic Le Meur](http://www.crunchbase.com/person/loic-le-meur).

SIRS Therapeutics

Seed Round in 2020
SIRS Therapeutics operates as a therapeutics company.

SENSIMED

Series C in 2012
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Nosto

Series A in 2014
Nosto brings solutions for online marketing automation for the global e-commerce industry. The company’s platform-independent SaaS solution enhances customers’ online shopping experience by enabling personalized product recommendations in real time. Its plug and play solution makes the technology easily accessible to online stores of all size, automating marketing activities and increasing conversion, customer retention and store revenues as a result. Nosto’s first customers include leading brands like Angry Birds, Intersport, JOY, Reima, Outnorth and Sanoma’s Huuto.

Edge Intelligence Software

Seed Round in 2013
Edge Intelligence Software, Inc. develops a relational database management system (RDBMS), which enables a single database to load large volumes of data in real time, whilst extracting information without the need for an interim index or data warehouse. The company’s product includes EdgeIntelligence which is an enterprise software solution that consists of three integrated components, including EdgiStore which is a data store that keeps everything and enables the query of anything; EdgiStar which provides the orchestration and access to a network of EdgiStores; and EdgiSafe that offers a seam of security that runs through everything to ensure the safety of all of the data stored at the edge of the network and the safety of any data moved across the network. Further, the company offers centralized management and access to terabytes of data which is collected and analyzed close to its source. The company was founded in 2010 and is based in San Francisco, California with an office location in Bristol, United Kingdom.

VoiceObjects

Series C in 2006
VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Industrial Origami

Series B in 2006
Industrial Origami offers patented metal folding designs and technologies through licenses, sub-licenses, and direct supply manufacturing aspects. The company’s technology allows thinner sheet material to be folded into complex and high load-bearing structures. It also enables its customers to incorporate its patented technology into their existing or new products by providing technology licenses and sub-licenses, as well as professional design services. Industrial Origami uses a patented technology that simplifies the design and assembly of products resulting in reduced product costs, innovative designs, and precision manufacture not possible using traditional forming methods. It also offers contract manufacturing through its partner network.
Garderos makes industrial-grade routers which are self-managing and cyber-secure. They work with their customers to make sure that their multi-site router projects are fully-functional and secure against cyber-attacks.

NexWave Solutions

Venture Round in 2005
NexWave Solutions, S.A. develops embedded and device software for the consumer electronics market. It offers NexGUI, a graphical user interface framework for set top boxes, personal video recorders, DTVs, cameras, and camcorders; NEXGUIBUILDER to design and generate applications that use NexGUI; and NEXBROWSER, a small-footprint HTML/XHTML/CSS/JavaScript browser. The company also provides Blu-ray stack that forms the core of the Blu-ray products; LibTRON to enable quick migration of µITRON applications and middleware to a Linux-based environment; and NSI (NexWave Software Infrastructure), a component-based software infrastructure for embedded software development. It has representations in Seoul, Korea; and Beijing, Shanghai, and Shenzhen in China. NexWave Solutions, S.A. was founded in 1998 and is headquartered in Montpellier, France with additional offices in Silicon Valley (Bay Area), California; and Tokyo, Japan.

Qype

Series A in 2008
Qype is a social network based around user reviews of businesses and places. The site allows its users to browse a database of locations and see at a glance those which have been most favorably rated by the community. Members of the site can add new places to the existing database, rate and review businesses, add videos and photos and engage with the community via message boards, groups and messaging. Founded in 2005 by German entrepreneur Stephan Uhrenbacher, the site also has a mobile version which can enables users to locate the top rated place near to a specified location.
Sapiens Steering Brain Stimulation GmbH is an emerging medical device company whose mission is to deliver superior solutions for deep brain stimulation (DBS) therapy. Sapiens' ambition is to provide a unique, high-resolution, and MRI- compatible DBS system that will improve patient comfort and therapeutic outcome, initially for patients with Parkinson's disease. Sapiens, with offices in Eindhoven, the Netherlands and Munich, Germany, is founded in 2011 as a spin-out of Royal Philips Electronics. Its steering brain stimulation (SBS) system and image-guided programming are based upon patented technologies.

AYOXXA

Series A in 2012
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.

NEUWAY Pharma

Series A in 2014
NEUWAY Pharma GmbH had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.

Polares Medical S.A.

Series B in 2020
Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

Implanet

Series C in 2010
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.

Orcan Energy

Series A in 2011
Orcan Energy is the leader in waste heat recovery technology. Orcan Energy GmbH was founded in 2008, as a spin-out from the Technical University of Munich (“TUM”). Orcan’s ePack offers a compact, service-reduced and cost- efficient “plug-and-play” waste heat power generator based on ORC-Technology. Spe- cific patented innovations enable Orcan to popularize the technology on the mass mar- ket. At the beginning of 2013, Orcan gained sponsorships from the Exist-Research- Transfer-Aid of the Federal Government of Germany and additional grants from the “Wissensfabrik” and various resources from the TUM.

Zopa

Venture Round in 2015
Zopa Limited owns and operates an online marketplace lending platform, which allows individuals in the United Kingdom to access unsecured loans, facilitated by funds provided by both individuals and institutions. The platform offers car loans, debt consolidation loans, home improvement loans, wedding loans, and peer-to-peer investments. Zopa Limited was incorporated in 2004 and is based in London, United Kingdom.

Implanet

Series A in 2007
Implanet S.A., together with its subsidiaries, designs, manufactures, and sells implants for orthopedic surgery in France, the United States, Brazil, and internationally. The company offers spinal, arthroscopy, and knee products. Its products include Jazz, Jazz Passer, Jazz Cap SP, Jazz Lock, Jazz Claw, Jazz Standalone, Jazz Frame, and Jazz Screw systems for posterior fixation. The company also offers knee prostheses, such as Madison for conventional surgical techniques. Implanet S.A. was founded in 2006 and is based in Martillac, France.